Related Experiment Videos
Multiple opiate receptors: déjà vu all over again
1Department of Neurology, Laboratory of Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. pasterng@mskcc.org
Neuropharmacology
|October 7, 2004
Summary
Discover the evolution of opioid receptor research, from initial proposals to the identification of multiple mu opioid receptors (MOR-1) and their splice variants. This research explains subtle pharmacological differences and guides future opioid studies.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- The understanding of opioid receptors has evolved significantly since their initial proposal.
- Three main opioid receptor families (mu, kappa, delta) are recognized.
- Clinical observations of opioid analgesics suggest complexities beyond single receptor interactions.
Purpose of the Study:
- To explore the hypothesis of multiple mu opioid receptor mechanisms.
- To investigate the role of mu opioid receptor (MOR-1) splice variants in opioid pharmacology.
- To provide a foundation for future research directions in opioid therapeutics.
Main Methods:
- Review of historical pharmacological data.
- Analysis of receptor binding studies.
- Examination of molecular cloning and splice variant identification.
Main Results:
- The cloning of the mu opioid receptor (MOR-1) provided a molecular basis for study.
- Identification of MOR-1 splice variants offers potential explanations for varied opioid effects.
- Pharmacological differences observed clinically are increasingly understood at a molecular level.
Conclusions:
- Multiple mu opioid receptors, including splice variants of MOR-1, are crucial for understanding opioid pharmacology.
- These molecular insights open new avenues for developing more targeted opioid analgesics.
- Further research into opioid receptor variants promises to refine pain management strategies.